Business Trip
Business Trip explores the frontiers of brain and mental health through conversations with founders, investors, and researchers at the intersection of neuroscience and technology.
Episodes
Jonathan Sporn (CEO + Founder of Gilgamesh Pharma) joins for a deep dive into next-gen psychedelic medicines, why duration matters for real-world clinical use, and what it takes to build these therapies the way large pharma would—culminating in a partnership with AbbVie worth up to $1.2B.
In this episode, we discuss:
• Why Gilgamesh is building psychedelic medicines the way large pharma would
• The thesis behind short-acti...
Greg speaks with three leaders in mental health philanthropy: Alyson Nieman from Mindful Philanthropy, Sabrina Gracias from Ortus Foundation, and Christena Huntsman Durham from Huntsman Mental Health Foundation, each offering a distinct perspective on how funding decisions get made and where the biggest gaps remain.
In this episode we discuss:
- Trends in mental health philanthropy, and the 10-year challenge: how the field moves fr...
Greg interviews Rick Perry, the former Governor of Texas and former U.S. Secretary of Energy and leading advocate for ibogaine, live at the Real Summit.
In this episode, we discuss:
- How a former Texas governor moved from strict opposition to drugs to becoming a leading advocate for ibogaine after firsthand experience and veteran outcomes.
- Ibogaine’s impact on PTSD, opioid addiction, and traumatic brain injury, including Stanford-l...
Matias interviews James (Jim) Gorman MD PhD from the Wyss Institute. Jim is Principal Investigator on the Wyss Institute Brain Targeting Program (BTP). Jim leads a team developing new approaches to transport drugs through the blood brain barrier (BBB) into the CNS.
In this episode, we discuss:
- Why the BBB blocks most modern drugs from entering the brain, creating the biggest bottleneck in neuro
- How brain shuttles hijack natural tr...
Greg and Matias interview Luis Voloch, CEO and Co-Founder of Jimini Health, an AI behavioral health company. He previously co-founded and served as CTO of Immunai, where he applied machine learning to immunology and drug discovery.
In this episode, we discuss:
- How LLMs expand the scope of machine learning from rule-based tasks to open-ended reasoning and dialogue
- Why healthcare adoption is tiered, beginning with clinician-facing...
Matias interviews Rob Malenka.
In this episode, we discuss:
- Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneous
- The bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatry
- How breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture ...
Greg and Matias interview Brendon Boot of Skin2Neuron. Brendon is a neurologist at Harvard and Mayo Clinic with prior experience as Medical Director at Biogen overseeing their Phase 1b Alzheimer’s trials.
In this episode, we discuss:
- How skin-derived cells can be turned into neurons to repair the brain.
- Why replacing lost neurons may succeed where drugs have failed in Alzheimer’s.
- What makes autologous (self-derived) cell therapy s...
Greg and Matias interview Natalie Yivgi-Ohana of Minovia. Natalie is a life science entrepreneur with twenty years’ experience in mitochondrial research and received her PhD in Biochemistry at The Hebrew University in 2007, after which she performed her postdoctoral fellowship at the Weizmann Institute of Science until 2010.
In this episode, we discuss:
- How mitochondria impacts health by not just regulating energy, but also horm...
Matias and Greg interview Ying-Hui Fu, PhD, is a Professor of Neurology at UCSF and a world leader in the genetics of sleep. Her lab has discovered the first-known genes behind “natural short sleepers”. Her work bridges human genetics and neuroscience to uncover how to modulate sleep for brain health, aging, and neurodegenerative diseases.
In this episode, we discuss:
- How some people thrive on 4–6 hours of sleep with rare genetic...
Matias and Greg interview Justin Mares, co-founder of TrueMed and Kettle & Fire on current US healthcare and how startups have the opportunity to change the system.
In this episode, we discuss:
- How the US system profits from chronic illness
- Fixing the food system, environmental toxins, pharma incentives & more
- Opportunities for founders building in brain and body health.
- Contrarian ideas Justin is investing in toda...
Matias and Greg interview Dr. Nir Grossman, one of the world’s leading researchers in neurotechnology. Nir is a lecturer in the Department of Brain Sciences at Imperial College London and a founding fellow of the UK Dementia Research Institute.
In this episode, we discuss:
- What is temporal interference (TI), a non-invasive stimulation method
- A comparison of TI with deep brain stimulation (DBS)
- How physics plays a crucial role in n...
Greg and Matias interview Dr. James Adams, professor and autism researcher at Arizona State University and President of Gut-Brain-Axis Therapeutics, on groundbreaking research in autism.
In this episode, we discuss:
- The latest advancements in microbiome therapy for autism
- How the gut-brain axis is shaping new therapeutic approaches
- The role of nutritional interventions in supporting individuals with autism
- Environmental factors and ...
Matias interviews Elizabeth Horn, founder of the 2m Foundation, on the current state of autism and what can we do about it.
In this episode, we discuss:
- The rising prevalence of autism and its impact on society
- How 2m Foundation is funding research and solutions
- Environmental and biological factors contributing to autism
- Philanthropy and venture capital through the Autism Impact Fund
Credits:
Created by Greg Kubin and M...
Matias and Greg interview Dana Watt, a Partner at Breakout Ventures, about genetic medicine for brain and mental health.
In this episode, we discuss:
- How genetic therapies work: addressing underlying causes, not just symptoms
- The opportunities and challenges for genetic therapies for brain health
- Exploring effective delivery of genetic payloads
- Commercial viability and insurance considerations
Greg and Matias interview Jay Sanguinetti, founder of Sanmai Technologies, a startup using transcranial focused ultrasound for the treatment of mental health conditions.
Jay has a background in academia, having worked at the University of Arizona and started the SEMA Lab (Science Enhanced Mindful Awareness).
In this episode, we discuss:
- The science behind transcranial focused ultrasound and its therapeutic potential for mental he...
Greg and Matias interview Tim Marjenin, a regulatory consultant at MCRA with 16 years of experience at the FDA, to discuss the regulatory landscape for neurotechnology devices.
Tim provides insights into the FDA approval process for neurotech devices, drawing from his extensive experience on the FDA's Neurostimulation-Neurology Devices Team. The episode explores the evolving field of neurotechnology and its regulatory challenge...
Greg and Matias interview Gurdane Bhutani, an investor at MBX Ventures, to discuss the impact of environmental toxins on health and the field of exposomics.
Gurdane is an expert in environmental health, with a background in Epidemiology and Environmental Health Sciences. He provided insights into the pervasive nature of environmental toxins and their implications for public health. This episode also has a guest appearance from Bruce...
Greg and Matias interview Josh Hardman, founder and editor of Psychedelic Alpha, to discuss the recent FDA advisory committee meeting on Lykos Therapeutics’ MDMA-assisted therapy for PTSD.
Josh is a leading writer covering the intersection of psychedelics and business. He provided live reporting and analysis of the AdComm meeting.
In this episode, we discuss:
- The FDA advisory committee process and its implications for drug approva...
Software, hardware, and biotechnology are playing an increasingly transformative role in our mental health and wellness. Join us as we discuss what investors look for in these new companies and how they separate what’s real — and what’s near-term — from what’s hype. We’ll explore AI-powered tools for mental health, the new area of “enerceuticals” (energy replacing the “pharma”), psychedelics, and why what’s in your gut is so import...
Matias hosted a panel at The Battery SF with renowned psychedelics experts, Nolan Williams, Allison Feduccia, Matt Baggott.
Nolan is a Stanford professor currently researching ibogaine among other areas in psychiatry and radiology, and he's a founder of TMS company Magnus Medical. Allison is the founder of Psychedelic Support, a platform providing psychedelic education, community and a provider directory. And Matt is ...
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by Audiochuck Media Company.
Listen to 'The Bobby Bones Show' by downloading the daily full replay.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.